Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 53

1.

Small molecules and big killers: the challenge of eliminating the latent HIV reservoir.

Migueles SA, Connors M.

Immunity. 2012 Mar 23;36(3):320-1. doi: 10.1016/j.immuni.2012.03.006.

PMID:
22444629
[PubMed]
Free Article
2.

Modeling latently infected cell activation: viral and latent reservoir persistence, and viral blips in HIV-infected patients on potent therapy.

Rong L, Perelson AS.

PLoS Comput Biol. 2009 Oct;5(10):e1000533. doi: 10.1371/journal.pcbi.1000533. Epub 2009 Oct 16.

PMID:
19834532
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Low-level HIV-1 replication and the dynamics of the resting CD4+ T cell reservoir for HIV-1 in the setting of HAART.

Sedaghat AR, Siliciano RF, Wilke CO.

BMC Infect Dis. 2008 Jan 2;8:2. doi: 10.1186/1471-2334-8-2.

PMID:
18171475
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Viral and latent reservoir persistence in HIV-1-infected patients on therapy.

Kim H, Perelson AS.

PLoS Comput Biol. 2006 Oct;2(10):e135. Epub 2006 Aug 28.

PMID:
17040122
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

The latent reservoir for HIV-1 in resting CD4+ T cells: a barrier to cure.

Siliciano JD, Siliciano RF.

Curr Opin HIV AIDS. 2006 Mar;1(2):121-8. doi: 10.1097/01.COH.0000209582.82328.b8.

PMID:
19372795
[PubMed]
6.

An anti-CD45RO immunotoxin eliminates T cells latently infected with HIV-1 in vitro.

McCoig C, Van Dyke G, Chou CS, Picker LJ, Ramilo O, Vitetta ES.

Proc Natl Acad Sci U S A. 1999 Sep 28;96(20):11482-5.

PMID:
10500202
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

An anti-CD45RO immunotoxin kills latently infected human immunodeficiency virus (HIV) CD4 T cells in the blood of HIV-positive persons.

Saavedra-Lozano J, McCoig C, Xu J, Cao Y, Keiser P, Ghetie V, Siliciano RF, Siliciano JD, Picker LJ, Ramilo O, Vitetta ES.

J Infect Dis. 2002 Feb 1;185(3):306-14. Epub 2002 Jan 8.

PMID:
11807712
[PubMed - indexed for MEDLINE]
Free Article
8.

Molecular characterization, reactivation, and depletion of latent HIV.

Brooks DG, Hamer DH, Arlen PA, Gao L, Bristol G, Kitchen CM, Berger EA, Zack JA.

Immunity. 2003 Sep;19(3):413-23.

PMID:
14499116
[PubMed - indexed for MEDLINE]
9.

Persistence of wild-type virus and lack of temporal structure in the latent reservoir for human immunodeficiency virus type 1 in pediatric patients with extensive antiretroviral exposure.

Ruff CT, Ray SC, Kwon P, Zinn R, Pendleton A, Hutton N, Ashworth R, Gange S, Quinn TC, Siliciano RF, Persaud D.

J Virol. 2002 Sep;76(18):9481-92.

PMID:
12186930
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Limits on replenishment of the resting CD4+ T cell reservoir for HIV in patients on HAART.

Sedaghat AR, Siliciano JD, Brennan TP, Wilke CO, Siliciano RF.

PLoS Pathog. 2007 Aug 31;3(8):e122.

PMID:
17784786
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Characterization of chemokine receptor utilization of viruses in the latent reservoir for human immunodeficiency virus type 1.

Pierson T, Hoffman TL, Blankson J, Finzi D, Chadwick K, Margolick JB, Buck C, Siliciano JD, Doms RW, Siliciano RF.

J Virol. 2000 Sep;74(17):7824-33.

PMID:
10933689
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

HIV-1 reactivation in HIV-latently infected dendritic cells by oral microorganisms and LPS.

Huang CB, Alimova YV, Ebersole JL.

Cell Immunol. 2011;268(2):105-11. doi: 10.1016/j.cellimm.2011.02.003. Epub 2011 Feb 19.

PMID:
21420664
[PubMed - indexed for MEDLINE]
13.

A lentiviral vector that activates latent human immunodeficiency virus-1 proviruses by the overexpression of tat and that kills the infected cells.

Macías D, Oya R, Saniger L, Martín F, Luque F.

Hum Gene Ther. 2009 Nov;20(11):1259-68. doi: 10.1089/hum.2009.059.

PMID:
19604078
[PubMed - indexed for MEDLINE]
14.

Decay of the HIV reservoir in patients receiving antiretroviral therapy for extended periods: implications for eradication of virus.

Chun TW, Justement JS, Moir S, Hallahan CW, Maenza J, Mullins JI, Collier AC, Corey L, Fauci AS.

J Infect Dis. 2007 Jun 15;195(12):1762-4. Epub 2007 May 2.

PMID:
17492591
[PubMed - indexed for MEDLINE]
Free Article
15.

Latent reservoirs of HIV: obstacles to the eradication of virus.

Chun TW, Fauci AS.

Proc Natl Acad Sci U S A. 1999 Sep 28;96(20):10958-61.

PMID:
10500107
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Can the viral reservoir of latently infected CD4(+) T cells be eradicated with antiretroviral HIV drugs?

Smith RJ, Aggarwala BD.

J Math Biol. 2009 Nov;59(5):697-715. doi: 10.1007/s00285-008-0245-4. Epub 2009 Jan 23.

PMID:
19165438
[PubMed - indexed for MEDLINE]
17.

A long-term latent reservoir for HIV-1: discovery and clinical implications.

Siliciano JD, Siliciano RF.

J Antimicrob Chemother. 2004 Jul;54(1):6-9. Epub 2004 May 26. Review.

PMID:
15163657
[PubMed - indexed for MEDLINE]
Free Article
18.
19.

A reservoir for HIV in patients on combination antiretroviral therapy.

Siliciano RF.

Hopkins HIV Rep. 1998 Jan;10(1):1, 5-6, 11.

PMID:
11365130
[PubMed - indexed for MEDLINE]
20.

Establishment of novel cell lines latently infected with human immunodeficiency virus 1.

Oh YT, Kim KC, Hong KJ, Lee HS, Jang DH, Lee JS, Choi SY, Kim SS, Choi BS.

Acta Virol. 2011;55(2):155-9.

PMID:
21692564
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk